Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil for Emergence Delirium in Remimazolam Anesthesia
NCT05681377Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Mar 2023
- Primary completion
- Aug 2023
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of flumazenil in emergence delirium (ED), sponsored by Korea University Guro Hospital. Started Mar 2023; status: completed.
02
Drugs
flumazenil
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT05681377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681377.